Finance

Upslope Capital flags Magnum Ice Cream as defensive buy amid speculative market

The Magnum Ice Cream Company N.V. holds approximately 21 per cent of the global market, significantly ahead of rival Froneri, according to Upslope Capital Management’s latest investor letter.

Author
Owen Mercer
Markets and Finance Editor
Published
Draft
Source: Yahoo Finance · original
Multiple Catalysts Spur Upslope Capital Management’s Latest Buy: Magnum Ice Cream (MICC)
Fund underperforms major indices in Q2 2026 but highlights the spun-out Unilever business for its global dominance and manageable GLP-1 exposure

Upslope Capital Management has identified The Magnum Ice Cream Company N.V. (NYSE:MICC) as a key investment in its second-quarter 2026 investor letter, citing the firm’s dominant global market position and defensive business model. The recommendation comes as the fund navigated a challenging market environment characterised by what the firm described as speculative mania, where investors broadly avoided what it termed "boring, cash-flowing, non-AI stocks."

The Magnum Ice Cream Company N.V. (NYSE:MICC) operates as a pure-play global ice cream business, having been spun out of Unilever at the end of 2025. As of July 21, 2026, the company reported a market capitalisation of $10.96 billion, with shares closing at $17.88. The stock has gained 12.81 per cent year-to-date and posted a one-month return of 4.99 per cent, reflecting investor interest in its established brand portfolio which includes Magnum, Ben & Jerry's, Cornetto, and Wall's.

Upslope Capital Management highlighted that Magnum holds approximately 21 per cent of the global ice cream market, a share almost double that of its nearest competitor, Froneri. The firm noted that beyond Magnum and Froneri, the largest players hold 2 per cent of the market or less. This concentration underscores Magnum’s competitive advantages, stemming from its ownership of leading global brands and a complex global frozen supply chain network.

A central theme in Upslope’s thesis is the manageable risk Magnum faces from GLP-1 weight-loss drugs, attributed to a lower concentration of sales in the United States. The firm cited that the United States accounts for approximately 25 per cent of total sales. The geographic distribution is balanced, with nearly 40 per cent of sales coming from the Americas and Europe/ANZ, while Asia, the Middle East, and Africa contribute 25 per cent. Emerging markets are identified as a key growth driver, contributing approximately 30 per cent of sales.

The decision to highlight Magnum contrasts with the broader performance of Upslope Capital Management’s fund, which returned -6.6 per cent (net) in the second quarter of 2026. This underperformance followed the S&P Midcap 400 ETF (MDY), which returned +14.3 per cent, and the HFRX Equity Hedge Index, which gained +10.3 per cent. Despite the fund’s recent results, Upslope maintains that Magnum’s defensive characteristics and global reach offer a compelling case for investment in the current climate.

Hedge fund interest in The Magnum Ice Cream Company N.V. (NYSE:MICC) has seen a slight decline, with 22 portfolios holding the stock at the end of the first quarter of 2026, down from 25 in the previous quarter. The firm noted that while Magnum presents potential, certain AI stocks may offer greater upside potential with less downside risk. Nevertheless, Upslope continues to view the ice cream manufacturer as a standout asset within its strategy to provide equity-like returns while reducing market risk.

Continue reading

More from Finance

Read next: Kimberly-Clark set to report Q2 2026 earnings amid cost headwinds and oil price risks
Read next: US imposes new tariffs on 60 nations citing forced labour probe
Read next: Giverny Capital flags JPMorgan earnings strength amid stock underperformance